The University of Chicago Header Logo

Connection

Mirjam Boelens to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Mirjam Boelens has written about Protein Kinase Inhibitors.
Mirjam Boelens
Connection Strength
0.076
Protein Kinase Inhibitors
  1. Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of epidermal growth factor receptor-mutated non-small-cell lung carcinoma patients developing leptomeningeal metastases: Osimertinib Resistance Analysis-leptomeningeal metastases study. Neuro Oncol. 2024 Dec 05; 26(12):2316-2327.
    View in: PubMed
    Score: 0.044
  2. The force of HER2 - A druggable target in NSCLC? Cancer Treat Rev. 2020 Jun; 86:101996.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.